Erlotinib
Also known as Tarceva (us), Erlonat (india)
Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better.
United States
$957
per month
India
$98
per month
You save
−90%save $859/mo · 90% cheaper
6.2K US scripts/yr$5.3M potential annual savings$5.9M US spend/yr
Drag to rotate · 3D structureC22H23N3O4
SMILES: COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
Compare the price
US price$957per month
India price$98per month
You save$85990% less
Based on 30 units per month. US $31.90 vs India $3.26 per unit.
Total over 1 periodSave $859$957 → $98
The bigger picture
Erlotinib is filled about 6.2K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$5.9M
If sourced from India
$603.2K
Potential annual savings
$5.3M
−90%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.